| ²é¿´: 616 | »Ø¸´: 1 | ||
| ¡¾ÐüÉͽð±Ò¡¿»Ø´ð±¾ÌûÎÊÌ⣬×÷ÕßµãµãÓðÂ佫ÔùËÍÄú 50 ¸ö½ð±Ò | ||
µãµãÓðÂä½ð³æ (ÕýʽдÊÖ)
|
[ÇóÖú]
¼±ÇóSASͳ¼Æ´óÉñ
|
|
|
SCIÎÄÕ¶þÉó£¬ÓÐûÓÐͳ¼Æ´óÉñ°¡£¬¶þÉóÆäÖÐÎÊÌ⣺ÔÚ2.5 Statistical analysis£ºÐè˵Ã÷SASͳ¼ÆÄ£Ê½°üÀ¨ÄÄЩÏîÄ¿£¿ÒÔ¼°·½²î·ÖÎöÓ°ÏìÏÔÖøÊ±£¬ÓÃɶ·½·¨½øÐи÷´¦ÀíÆ½¾ùÊý¼äµÄ²îÒìÏÔÖøÐÔ¼ìÑ飿 ֮ǰÎÒдµÄ 2.5 Statistical analysis The treatment effects were assessed by the GLM procedure of ANOVA (version 9.4, SAS inst, Inc., Cary, NC), where pen was the statistical unit. The linear and quadratic effects of saccharicterpenin level were assessed using orthogonal polynomials. P < 0.05 was used as the criterion for statistical significance. ÎÒÐèÒªÔõôÐ޸ĸ÷λ´óÉñ°ï°ïæ¡£ |
» ²ÂÄãϲ»¶
Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
Ò»Ö¾Ô¸±±¾©»¯¹¤´óѧ£¬³õÊԳɼ¨350Çóµ÷¼Á
ÒѾÓÐ14È˻ظ´
¸´ÊÔµ÷¼Á
ÒѾÓÐ4È˻ظ´
323·Ö£¨¼ÆËã»úÊÓ¾õºÍ´óÄ£ÐÍÏîÄ¿£©ÄÜÖ±½ÓÉÏÊÖ
ÒѾÓÐ3È˻ظ´
311·Ö 22408 Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
320·ÖÈ˹¤ÖÇÄܵ÷¼Á
ÒѾÓÐ7È˻ظ´
Ò»Ö¾Ô¸Ö£´ó0705Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
0703»¯Ñ§
ÒѾÓÐ10È˻ظ´
301Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
306·Ö²ÄÁÏÓ뻯¹¤Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´

µãµãÓðÂä
½ð³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 1044.9
- É¢½ð: 76
- ºì»¨: 4
- ɳ·¢: 1
- Ìû×Ó: 706
- ÔÚÏß: 84.8Сʱ
- ³æºÅ: 7115343
- ×¢²á: 2017-08-29
- רҵ: ÐóÄÁѧ

2Â¥2019-04-04 15:17:33














»Ø¸´´ËÂ¥